Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis. (2023). SKIN The Journal of Cutaneous Medicine, 7(6), s276. https://doi.org/10.25251/skin.7.supp.276